Las Vegas, NV -- (SBWIRE) -- 03/22/2013 -- Titan Pharmaceuticals, Inc. (OTC:TTNP) is moving in bullish trend today and gained about 33 percent during afternoon trading hours. Currently the stock is trading at about $1.63. The stock opened at $1.89 today, saw multiple ups and down during trading session. The company has highest of $2.53 in last 52 weeks.
The advisory board is recommending approval for Titan Pharmaceuticals Inc’s opioid treatment. The discussion was made at Silver Spring Maryland for evaluating the safety concerns and effectiveness of the drug Probuphine. However FDA has concern over the effective dosage of the drug.
Probuphine is implanted surgically under the skin for medicine release. The treatment will be a step forward in the field of medical sciences and could be profitable for the company as well. But FDA is still concerned about the dosage of the medicine needed to be implanted. Further the factors such as risk involved in implantation and removal of medicine, and its mitigation strategy was also under discussion by FDA.
To find out what OTCMAGIC projects for Titan Pharmaceuticals Inc Inc for both short term and long term please click here: TTNP
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in OTC Picks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)